News
The first systematic review on the effects of bipolar medications on the gut microbiome has concluded that the health of the gut microbiome may predict a patient’s response to drug treatment.
11d
Inquirer.net - Philippines Entertainment News on MSNFifth Solomon diagnosed with bipolar disorder, taking medicationFifth Solomon revealed he was clinically diagnosed with bipolar disorder, saying he has started taking medication which has helped him feel "present and in control" again. Bipolar ...
Pune: For a woman in her 50s, life after divorce became an unbearable struggle. Constant mood swings left her irritable and ...
Anxiety can be thought of as the psychological equivalent of pain. Although only a subset of mental health conditions contain the word "anxiety," it can be a symptom of more. Missing a condition ...
13d
News-Medical.Net on MSNGenetic markers show promise in predicting mood disorder treatment outcomesIn a comprehensive Genomic Press Thought Leaders Invited Review, researchers have synthesized findings from dozens of studies ...
Offering proven success and lasting results, ketamine represents hope and healing in the treatment of depression, anxiety, ...
Researchers have completed the first systematic review to explore the connection between bipolar medications and the gut microbiome, providing fresh insights into the complex relationship between the ...
Two specific types of antidepressants – selective serotonin reuptake inhibitors (SSRIs) and tricyclics (TCAs) – may make ...
Sa pamamagitan ng Instagram kahapon, June 23, 2025, ibinahagi ni Fifth ang mga nararamdaman niya bago pa man siya ma-diagnose ...
Caplyta (lumateperone) was approved for the treatment of schizophrenia in 2019 and for depressive episodes linked to bipolar I or bipolar II disorder (bipolar depression) in 2021.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results